E2F8 and breast cancer: As expected, luciferase reporter assays revealed that overexpression of E2F8 activated, whereas downregulation of E2F8 attenuated, the luciferase activity of CCNE1 and CCNE2 promoters in breast cancer cells in a dose-dependent manner (Figure 6C, 6D).